| Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer CH Chiang, CH Chiang, CH Chiang, KSK Ma, CY Peng, YP Hsia, ... Heart 109 (6), 470-477, 2023 | 19 | 2023 |
| Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitors CH Chiang, CH Chiang, CY Peng, YP Hsia, XY See, CS Horng, ... European Journal of Cancer 174, 1-9, 2022 | 18 | 2022 |
| The association between baseline proton pump inhibitors, immune checkpoint inhibitors, and chemotherapy: a systematic review with network meta-analysis Y Chang, WY Lin, YC Chang, CH Huang, HE Tzeng, E Abdul-Lattif, ... Cancers 15 (1), 284, 2022 | 8 | 2022 |
| Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study CH Chiang, YJ Chen, CH Chiang, CY Chen, YC Chang, SS Wang, ... Cancer Immunology, Immunotherapy 72 (6), 1951-1956, 2023 | 7 | 2023 |
| Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis WY Lin, SS Wang, YN Kang, AS Porpiglia, Y Chang, CH Huang, ... Frontiers in Pharmacology 13, 1048980, 2022 | 5 | 2022 |
| The Effect of Renin–Angiotensin–Aldosterone System Inhibitors on Outcomes of Patients Treated with Immune Checkpoint Inhibitors: a Retrospective Cohort Study CH Chiang, SS Wang, YC Chang, CY Chen, YJ Chen, XY See, CY Peng, ... Clinical Oncology 35 (7), 446-453, 2023 | 4 | 2023 |
| Effects of corticosteroids on severe community-acquired pneumonia: a closer look at the evidence CH Chiang, XY See, TH Wang, YC Chang, JE Lo, WT Liu, CYW Choo, ... Critical Care 27 (1), 336, 2023 | 3 | 2023 |
| Efficacy of lipophilic statins on outcomes of patients treated with immune checkpoint inhibitors CH Chiang, YJ Chen, XY See, YC Chang, SS Wang, CY Peng, CS Horng, ... Oncology 101 (9), 537-541, 2023 | 2 | 2023 |
| The impact of peroxisome proliferator‐activated receptor‐γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy CH Chiang, YC Chang, SS Wang, YJ Chen, XY See, CY Peng, YP Hsia, ... Cancer Medicine 12 (8), 9583-9588, 2023 | 2 | 2023 |
| The Effect of Exercise on Cardiotoxicity in Women with Breast Cancer Receiving Anthracycline-Based Chemotherapy: A Systematic Review and Meta-Analysis CH Chiang, YC Chang, Y Haw, JY Tan, CH Chiang, YP Hsia, CH Chiang Oncology 102 (6), 510-514, 2024 | 1 | 2024 |
| The impact of sodium‐glucose cotransporter‐2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancer CH Chiang, CH Chiang, YP Hsia, A Jaroenlapnopparat, CS Horng, ... Journal of Gastroenterology and Hepatology, 2024 | 1 | 2024 |
| The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER-Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis YC Chang, J Song, Y Chang, CH Huang, A Sudan, PC Chen, KY Chi Cancers 15 (21), 5133, 2023 | 1 | 2023 |
| The impact of glucagon-like peptide-1 receptor agonists on proteasome inhibitor-associated cardiotoxicity in patients with multiple myeloma. YC Chang, CH Chiang, Z Tang, XY See, CH Chiang, KY Chi, Y Chang, ... Journal of Clinical Oncology 42 (16_suppl), e24008-e24008, 2024 | | 2024 |
| The impact of glucagon-like peptide 1 agonists on anthracycline or human epidermal growth factor receptor 2 inhibitor-associated cardiotoxicity in patients with breast cancer … CH Chiang, YC Chang, Z Tang, XY See, KY Chi, Y Chang, CH Chiang, ... Journal of Clinical Oncology 42 (16_suppl), 12026-12026, 2024 | | 2024 |
| Direct oral anticoagulant versus low molecular weight heparin for venous thromboembolism in patients receiving immune checkpoint inhibitors. CH Chiang, YC Chang, Z Tang, XY See, KY Chi, Y Chang, CH Chiang, ... Journal of Clinical Oncology 42 (16_suppl), 12127-12127, 2024 | | 2024 |
| The association between osimertinib and nutritional deficiency among patients with non-small cell lung cancer. Z Tang, CH Chiang, YC Chang, XY See, Q Wang, A Dowlati, CH Chiang, ... Journal of Clinical Oncology 42 (16_suppl), 8031-8031, 2024 | | 2024 |
| The effect of sodium glucose cotransporter-2 inhibitors on mortality and cardiovascular outcomes of patients with prostate cancer receiving luteinizing hormone releasing … Z Tang, CH Chiang, YC Chang, XY See, Q Wang, KY Chi, CH Chiang Journal of Clinical Oncology 42 (16_suppl), 12025-12025, 2024 | | 2024 |
| Risk factors for thrombotic events among patients taking immune checkpoint inhibitors: A systematic review and meta-analysis. J Song, AY Caceres Lessa, PL Lee, I Chowdhury, Y Chang, YC Chang, ... Journal of Clinical Oncology 42 (16_suppl), e14610-e14610, 2024 | | 2024 |
| Apixaban versus warfarin for primary thromboprophylaxis in patients with multiple myeloma undergoing immunomodulatory treatment. YC Chang, CH Chiang, Z Tang, XY See, CH Chiang, KY Chi, Y Chang, ... Journal of Clinical Oncology 42 (16_suppl), 7548-7548, 2024 | | 2024 |
| Anticoagulation Strategies in Non-critically Ill COVID-19 Inpatients: A Systematic Review and Meta-analysis XY See, O Ahmed, CH Chiang, CY Peng, YC Chang, WT Liu, ZH Wang, ... B67. VIRAL RESPIRATORY INFECTIONS INSIGHTS, A4196-A4196, 2024 | | 2024 |
